Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
Andre W. Bourgoyne, Bloodless Program Consultant at UChicago Medicine shared a post on LinkedIn:
“Anemia Management Is a Hospital Performance Strategy – Not Just a Lab Value
Preoperative anemia is one of the strongest predictors of surgical complications, longer hospital stays, and increased mortality.
Yet many hospitals still treat anemia reactively.
Forward-thinking institutions are shifting to Preoperative anemia management initiatives.
Why it matters:
- Fewer transfusions
- Lower complication rates
- Reduced ICU utilization
- Shorter length of stay
- Improved quality metrics
- Stronger financial performance
Optimizing hemoglobin before surgery with IV iron, B12, folate, nutrition, and appropriate EPO support doesn’t just protect patients – it protects institutional outcomes.
Anemia management is:
- Risk reduction
- Cost containment
- Outcome optimization
- Strategic differentiation
Hospitals that strengthen the blood before surgery strengthen their brand, their margins, and their mission.
Stay updated with Hemostasis Today.
-
Mar 22, 2026, 16:03Fibrinogen-Guided Management of Postpartum Hemorrhage – Transfusion Medicine KMC Manipal
-
Mar 22, 2026, 15:48Simon Senanu: Diagnostic Significance of Target Cells in Peripheral Blood Smear
-
Mar 22, 2026, 15:43Hayley Evans: What If The Decision Support System Is Part of The Problem?
-
Mar 22, 2026, 15:29Archit Pandharipande: The Burden and Impact of Heavy Menstrual Bleeding in Adolescents with Bleeding Disorders
-
Mar 22, 2026, 15:17Mamtha Balla: Mastering the Lab and Clinical Connection in Hemostasis and Thrombosis
-
Mar 22, 2026, 14:53Daniel Torrent: Amputation Is Not Inevitable in CLTI
-
Mar 22, 2026, 14:46Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
-
Mar 22, 2026, 14:26Hussien Hishmat: Pulmonary Embolism – How Does Risk Dictate Management
-
Mar 22, 2026, 14:12Bruno Pougault: Oral Anticoagulants Are Essential, But Not a ‘Fix-All’